Literature DB >> 21792840

Response to rituximab in patients with rheumatoid arthritis in different compartments of the immune system.

Maria J H Boumans1, Rogier M Thurlings, Danielle M Gerlag, Koen Vos, Paul P Tak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21792840     DOI： 10.1002/art.30567

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  12 in total

1.  B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsets.

Authors:  E Becerra; I De La Torre; M J Leandro; G Cambridge
Journal:  Clin Exp Immunol       Date:  2017-09-25       Impact factor: 4.330

2.  Novel assessment tools to evaluate clinical and laboratory responses in a subset of patients enrolled in the Rituximab in Myositis trial.

Authors:  Lisa G Rider; Adrienne L Yip; Iren Horkayne-Szakaly; Rita Volochayev; Joseph A Shrader; Maria L Turner; Heidi H Kong; Minal S Jain; Anna V Jansen; Chester V Oddis; Thomas A Fleisher; Frederick W Miller
Journal:  Clin Exp Rheumatol       Date:  2014-07-28       Impact factor: 4.473

3.  Can NK cells purge HIV sanctuaries?

Authors:  Madeleine J Bunders; Marcus Altfeld
Journal:  Nat Med       Date:  2017-11-07       Impact factor: 53.440

Review 4.  Synovial tissue research: a state-of-the-art review.

Authors:  Carl Orr; Elsa Vieira-Sousa; David L Boyle; Maya H Buch; Christopher D Buckley; Juan D Cañete; Anca I Catrina; Ernest H S Choy; Paul Emery; Ursula Fearon; Andrew Filer; Danielle Gerlag; Frances Humby; John D Isaacs; Søren A Just; Bernard R Lauwerys; Benoit Le Goff; Antonio Manzo; Trudy McGarry; Iain B McInnes; Aurélie Najm; Constantino Pitzalis; Arthur Pratt; Malcolm Smith; Paul P Tak; Rogier Thurlings; João E Fonseca; Douglas J Veale; Sander W Tas
Journal:  Nat Rev Rheumatol       Date:  2017-07-13       Impact factor: 20.543

5.  CD4+ count-dependent concentration-effect relationship of rituximab in rheumatoid arthritis.

Authors:  Amina Bensalem; Denis Mulleman; Gilles Thibault; Nicolas Azzopardi; Philippe Goupille; Gilles Paintaud; David Ternant
Journal:  Br J Clin Pharmacol       Date:  2019-11-22       Impact factor: 4.335

Review 6.  B-cell survival factors in autoimmune rheumatic disorders.

Authors:  Sandra A Morais; Andreia Vilas-Boas; David A Isenberg
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-08       Impact factor: 5.346

7.  Efficacy of B cell depletion therapy for murine joint arthritis flare is associated with increased lymphatic flow.

Authors:  Jie Li; Yawen Ju; Echoe M Bouta; Lianping Xing; Ronald W Wood; Igor Kuzin; Andrea Bottaro; Christopher T Ritchlin; Edward M Schwarz
Journal:  Arthritis Rheum       Date:  2013-01

Review 8.  Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?

Authors:  Ae R Noort; Paul P Tak; Sander W Tas
Journal:  Arthritis Res Ther       Date:  2015-01-28       Impact factor: 5.156

Review 9.  B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies.

Authors:  Maria J Leandro
Journal:  Arthritis Res Ther       Date:  2013-03-25       Impact factor: 5.156

10.  Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement.

Authors:  Sai S Duraisingham; Matthew Buckland; John Dempster; Lorena Lorenzo; Sofia Grigoriadou; Hilary J Longhurst
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.